Therapeutic Potential of Mesenchymal Stem Cells in postmenopausal-related muscle wasting: a preclinical study
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
AbstractAgeing-related loss of skeletal muscle mass, or sarcopenia, leads to the loss of functional mobility and independence in elderly people. Postmenopausal populations are under high risk of suffering from sarcopenia.
Recent researches have shown Mesenchymal stem cells (MSCs) have the potential for regenerative medicine and also MSCs have been used as a therapy for treating a variety of disease, including skeletal muscle-related disease. Therefore, evidence has established MSCs as a candidate for stem cell transplant therapy with the possibility of attenuating postmenopausal-related muscle wasting.
All Author(s) ListBelle Yu-Hsuan WANG, Oscar K. Lee, Chien-Wei LEE, Wayne Yuk-Wai LEE
Name of Conference6th Asian Conference for Frailty & Sarcopenia
Start Date of Conference30/10/2020
End Date of Conference31/10/2020
Place of ConferenceVirtual
Country/Region of ConferenceOthers
Year2020
Month10
LanguagesEnglish-United Kingdom

Last updated on 2021-30-11 at 15:38